Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Supply of Tacrolimus Capsules

Active

Federal

Response Deadline09/16/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0033.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Tacrolimus Capsules

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedSep 4

subcontract

Response DeadlineSep 16

Submission deadline

Response Deadline

09/16/2026, 07:30:00 PM UTCin 11 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies Tacrolimus Capsules for prime contractors on Department of Veterans Affairs (VA) pharmaceutical supply projects. Manufactures or sources capsules, assigns a unique National Drug Code (NDC), and performs primary labeling without over-labeling. Coordinates delivery through VA and DoD Pharmaceutical Prime Vendor Programs. Requires FDA regulatory compliance and a unique NDC number. Delivers Tacrolimus Capsules to Prime Vendor distribution centers.

Similar Contracts

Same NAICS industry code

6505--Tacrolimus Capsules

Solicitation # 36E79726R0033

The Department of Veterans Affairs National Acquisition Center is issuing an unrestricted solicitation under NAICS code 325412 for the procurement of Tacrolimus Capsules. This contract aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a one-year base period with four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item procedures, with a tentative closing date of September 15, 2026. The scope of work includes the supply of three different strengths of Tacrolimus Capsules: 0.5mg, 1mg, and 5mg, with estimated annual quantities of 51,904, 142,788, and 5,207 bottles respectively, each in package sizes of 100. Strict labeling requirements are in place, requiring the offeror to provide the exact drug name and a unique NDC number belonging to the offeror. The contractor's label must be the only label on the product, and affixing labels over existing labels is strictly prohibited. All proposals and documentation are managed electronically via sam.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Veterinary Rabies Vaccine Supplier (IMRAB 3)This subcontract is for the supply of IMRAB 3 veterinary rabies vaccines to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies thimerosal-free, killed virus vaccines that provide three years of protection. All deliverables must adhere to the DLA Master List of Technical and Quality Requirements, comply with DFARS 252.204-7018, and be marked according to Medical Marking Standard No. 1. The opportunity is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance is designated for APO 09227-0000. Interested parties must respond by September 9, 2026, to provide the specified quantity of vaccines meeting all quality and marking standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Oral Rehydration Powder Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Salicylic Acid Plaster Supplier/ManufacturerThis subcontract under the Department of Defense Medical Supply Chain involves the manufacture and supply of Salicylic Acid Plasters for prime contractors on DLA supply contracts. The required product must adhere to NSN 6510-01-120-2643 specifications, featuring a composition of 40 percent salicylic acid and 60 percent base, measuring 5.08 cm by 7.62 cm with a flannel back. The supplier is responsible for managing production to ensure a 24 month shelf life, with no more than 3 months elapsed at the time of delivery. Products must be delivered in packages of 25 plasters each. This opportunity falls under NAICS code 325412 and was posted on September 3, 2026, with a response deadline of September 9, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sumatriptan Succinate Tablets Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Hexagon Head Cap Screw Supply

AVIATION SUPPLY CHAIN ESOC BUYS

POSTED

DEADLINE

Supply of Multivitamin Solution for Injection (NSN 6505-0165-84941)This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of multivitamin solution for injection, identified by NSN 6505-0165-84941. The provider will supply the product configured as two 5 ML vials per 10 ML dose, delivered in sterile vials with accompanying Safety Data Sheets. To qualify, contractors must possess a CAGE code and valid FDA pharmaceutical licensing. A critical component of this contract is the management of cold chain logistics, requiring medical-grade refrigeration to maintain a strict temperature range between 2 and 8 degrees Celsius during both storage and transit. The performance location is designated as FPO 96678, with the response deadline set for September 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Sodium Chloride Ophthalmic Solution, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Povidone-Iodine Topical Solution SupplierThis subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture and supply of Povidone-Iodine Topical Solution for prime contractors. The supplier must ensure all products conform to USP standards and are delivered with a minimum remaining shelf life of 31 months. All materials must be packaged commercially according to ASTM D3951 standards and delivered in packages of 50 bottles. The supplier is required to certify the domestic origin of the product and its compliance with USP specifications. Performance for this contract is based in San Antonio, Texas, under NAICS code 325412. The response deadline for this opportunity is September 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Benzoin Tincture, Compound (USP)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lidocaine Hydrochloride AmpulesThis subcontract opportunity with the Department of Defense, specifically the Medical Supply Chain MD Surg FSF, seeks a provider to supply 2mL ampules of 1% lidocaine hydrochloride for prime contractors. The selected vendor must be capable of manufacturing or distributing pharmaceutical-grade lidocaine that adheres strictly to United States Pharmacopeia standards and must possess the necessary FDA pharmaceutical manufacturing or distribution licenses. The contract is categorized under NAICS code 325412 and is to be performed in San Antonio, Texas. Interested parties must submit their responses by September 9, 2026, following the posting date of September 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

36E79726R0032 Lisinopril Tablets (VA-27-00004937)

Solicitation # 36E79726R0032

The Department of Veterans Affairs is conducting an unrestricted procurement under solicitation 36E79726R0032 to secure an uninterrupted source of supply for Lisinopril Tablets. This contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four pre-priced one-year option periods. The procurement is issued in a commercial item format in accordance with FAR Part 12, with a tentative solicitation release date of September 3, 2026, and a response deadline of September 24, 2026. The scope of work includes the supply of Lisinopril tablets in various strengths ranging from 2.5mg to 40mg, with specific annual quantity requirements for various bottle sizes. Strict packaging and labeling standards are mandated, requiring a unique NDC number and the exact drug name on the label. For specific unit-of-use packaging, bottles must be cylindrical with a minimum 120cc volume and a 5.75 inch circumference to accommodate a 5.25 by 2 inch label. Additionally, these bottles must feature a safety cap that is either convertible or deshellable. The contractor's label must be the only label on the product and must allow VA labels to adhere securely on top. All proposals and communications are handled electronically via SAM.gov.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Distribution and Fulfillment

General Line Grocery Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling Services

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Ticagrelor Tablet Manufacturing

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Ticagrelor Tablets

Solicitation # 36E79726R0028

Solicitation 36E79726R0028 is an unrestricted, firm-fixed-price, indefinite-delivery requirements contract issued by the Department of Veterans Affairs National Acquisition Center to establish a reliable source of supply for Ticagrelor Tablets. The procurement supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four one-year options. Award will be granted to the lowest-priced, technically acceptable offeror, with evaluation based on the total price of the base requirement plus all option years. The scope includes six line items for Ticagrelor 60mg and 90mg tablets in various bottle sizes, ranging from 60-count unit-of-use bottles to 1,000-count bulk bottles. Strict packaging and labeling standards are required, including the use of cylindrical non-glass bottles with a minimum 120cc volume and 5.75-inch circumference, safety caps that are convertible or deshelled, and unique 11-digit NDC numbers. All products must be compatible with automated dispensing units and feature GS1-128 or HIBC linear bar codes and 2D data matrix codes per DSCSA requirements. Eligible offerors must maintain an active SAM record and provide proof of FDA cGMP acceptability for their manufacturing facilities. Those who are not the manufacturer must provide a signed Letter of Commitment ensuring a sufficient supply for the contract duration. Distribution will be managed through Government Prime Vendor contracts, with deliveries made to approximately 56 VA and DoD distribution centers nationwide. Proposals must be submitted in PDF or Word format, including a signed SF-1449 and pricing for all five years, with prices held firm for 120 calendar days.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Specialized Pharmaceutical Logistics (Cold Chain)

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Influenza Virus Vaccine Supplier

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--2027-2028 Influenza Virus Vaccine

Solicitation # 36E79726R0035

The Department of Veterans Affairs National Acquisition Center intends to issue an unrestricted Request for Proposal, solicitation 36E79726R0035, for the procurement of Influenza Virus Vaccines for the 2027-2028 season. This commercial item procurement, conducted under FAR Part 12, supports the VA, State Veteran Homes option 2, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. The requirement covers three primary vaccine presentations provided in boxes of 10 pre-filled single-dose syringes: a general version for persons 36 months and older, a version specifically designed for those 65 and older, and a pediatric version for children 6 to 35 months. All vaccines must be latex and preservative free, with the senior and pediatric versions requiring FDA approval. The final strain presentation, Trivalent or Quadrivalent, will be determined by World Health Organization recommendations, with a preference for Trivalent if both are available. Evaluation and award will be conducted by solicitation line item. While offerors do not need to bid on every item, they must offer the full quantity for any item they bid on and maintain consistent unit pricing for a single presentation. Final pricing must include the Federal Excise Tax and Cost Recovery Fee. Delivery is required Free On Board Destination to facilities in the United States, Puerto Rico, and the Philippines. For most facilities, at least 50 percent of the order must be delivered between August 15 and September 15, 2027, with the remainder delivered by October 15, 2027. The Captain James A. Lovell Federal Health Care Center must receive 100 percent of its awarded quantity between August 15 and September 15, 2027. The RFP is expected to be issued around September 8, 2026, with a closing date of September 24, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Logistics and Distribution via Pharmaceutical Prime Vendor Programs

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Labeling and Over-Label Adhesion Services

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Unit-of-Use Pharmaceutical Bottle Supply

All Other Plastics Product Manufacturing

POSTED

DEADLINE